PRKDC and breast cancer: Using the CPTAC dataset, we evaluated the PRKDC phosphorylation level in tumor tissues as well normal tissues in 6 kinds of cancers, including breast cancer, colon cancer, clear cell RCC, UCEC, LUAD, and ovarian cancer.